C669-2630 Screening compound: 4-chloro-N-{3-[(1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)amino]quinoxalin-2-yl}benzene-1-sulfonamide

C669-2630 Screening compound: 4-chloro-N-{3-[(1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)amino]quinoxalin-2-yl}benzene-1-sulfonamide
C669-2630 Screening compound: 4-chloro-N-{3-[(1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)amino]quinoxalin-2-yl}benzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C669-2630
4-chloro-N-{3-[(1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)amino]quinoxalin-2-yl}benzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C669-2630

Molecular Formula

C23H19ClN6O3S (C23 H19 ClN6 O3 S)

Compound Name

4-chloro-N-{3-[(1,3-dimethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl)amino]quinoxalin-2-yl}benzene-1-sulfonamide

IUPAC name

4-chloro-N-{3-[(13-dimethyl-2-oxo-23-dihydro-1H-13-benzodiazol-5-yl)amino]quinoxalin-2-yl}benzene-1-sulfonamide

SMILES

CN(c(ccc(Nc1nc2ccccc2nc1NS(c(cc1)ccc1Cl)(=O)=O)c1)c1N1C)C1=O

InChI

InChI=1S/C23H19ClN6O3S/c1-29-19-12-9-15(13-20(19)30(2)23(29)31)25-21-22(27-18-6-4-3-5-17(18)26-21)28-34(32,33)16-10-7-14(24)8-11-16/h3-13H,1-2H3,(H,25,26)(H,27,28)

InChI Key

UHVSLCFTVHEGFQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14780834

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

494.96

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.607

Distribution Coefficient, logD

3.061

Water Solubility, LogSw

-4.71

Polar Surface Area

85.698

Acid Dissociation Constant (pKa)

5.87

Base Dissociation Constant (pKb)

4.36

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

8.70

C669-2630 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-Inflammatory Library (24602 compounds)

Anticancer Library (62698 compounds)

Antiviral Library (67538 compounds)

C-Met Library (15277 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Immune system
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
  • Kinases
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C669-2630 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C669-2630?
Check Price and Availability of C669-2630, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C669-2630 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C669-2630
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C669-2630
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C669-2630 available by request